Home page Schedule details
About APSCVIR Organizing Committee Program Program-at-a-Glance Detailed Program Faculty Abstract Results Abstract Registration Dining Arrangements Hotel Reservation Visa Grant Application Sponsorship Venue Introduction Venue Touring Transportation About Suzhou Download Center Contact Us Log in
Li-Nan Yin
Harbin Medical Univisity Cancer Hospital, China
View Biography

The combined treatment ofTACE and HAIC with molecular targeted drugs and ICIs has shown efficacy in the management of unresectable hepatocellular carcinoma (HCC) and may offer significant survival benefits. However, not all patients benefit equally from this quadruple therapy [TACE-HAIC combined with molecular targeted drugs and ICIs], which underscores the need to establish a predictive model for assessing the prognosis of unresectable HCC patients following this treatment regimeMethods.